SOLVED: In section 1.10, times to death or relapse (in days) are given for 23 non-Hodgkin's lymphoma (NHL) patients, 11 receiving an allogenic (Allo) transplant from an HLA-matched sibling donor, and 12 patients receiving an autologous (Auto) transplant. Additionally, data on 20 Hodgkin's lymphoma (HOD) patients is provided, with 5 receiving an allogenic (Allo) transplant from an HLA-matched sibling donor and 15 patients receiving an autologous (Auto) transplant. To test for any difference i

HLA-A antibodies from Thermo Fisher Scientific

HH-66 Toluene Free Vinyl Cement, 8 oz. can - RH Adhesives